(Q44556507)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Tamás Masszi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Tamás Masszi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

14

Wieslaw Wiktor-Jedrzejczak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

11

Sebastian Giebel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1

Grzegorz W Basak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Gabor Mikala

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Ozren Jaksic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Sandra Basic-Kinda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Andrea Cegledi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Marienn Reti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Jiri Mayer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Kai Hübel

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Boris Labar

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

12 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

1711-1719

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663509%20AND%20SRC:MED&resulttype=core&format=json

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

Improving stem cell mobilization strategies: future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.578312